Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

A recent study found that the homeostasis model assessment insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI), and fasting glucose/insulin ratio (FGIR) were ...

Texas Health Resources is suing major insulin manufacturers and pharmacy benefit managers for allegedly colluding to drive up the price of insulin. The groups have called similar lawsuits "baseless." ...

At the center of their discovery is a protein called S100A9, which has been shown to reduce dangerous levels of ketones in the blood—without relying on insulin. For people living with type 1 ...

By Michael D. Shear Reporting from London Seven pediatric doctors and toxicology experts said on Thursday that jurors were misled by prosecutors who cited unreliable insulin tests during the trial ...

Expanded partnership with Google Cloud will expand availability to Cresta's solutions, enabling more contact centers to accelerate the adoption of AI transformation Cresta combines the best of ...